You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART Trial
|
|---|---|
| Published in |
PLOS Medicine, May 2012
|
| DOI | 10.1371/journal.pmed.1001217 |
| Pubmed ID | |
| Authors |
Diana M. Gibb, Hilda Kizito, Elizabeth C. Russell, Ennie Chidziva, Eva Zalwango, Ruth Nalumenya, Moira Spyer, Dinah Tumukunde, Kusum Nathoo, Paula Munderi, Hope Kyomugisha, James Hakim, Heiner Grosskurth, Charles F. Gilks, A. Sarah Walker, Phillipa Musoke, on behalf of the DART trial team |
| Abstract |
Few data have described long-term outcomes for infants born to HIV-infected African women taking antiretroviral therapy (ART) in pregnancy. This is particularly true for World Health Organization (WHO)-recommended tenofovir-containing first-line regimens, which are increasingly used and known to cause renal and bone toxicities; concerns have been raised about potential toxicity in babies due to in utero tenofovir exposure. |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 33% |
| United Kingdom | 4 | 19% |
| France | 1 | 5% |
| Mexico | 1 | 5% |
| Egypt | 1 | 5% |
| Unknown | 7 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 71% |
| Practitioners (doctors, other healthcare professionals) | 4 | 19% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
| Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 398 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Czechia | 3 | <1% |
| Peru | 2 | <1% |
| Ethiopia | 1 | <1% |
| Brazil | 1 | <1% |
| France | 1 | <1% |
| Canada | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 388 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 69 | 17% |
| Researcher | 49 | 12% |
| Student > Ph. D. Student | 43 | 11% |
| Student > Bachelor | 40 | 10% |
| Student > Postgraduate | 29 | 7% |
| Other | 81 | 20% |
| Unknown | 87 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 170 | 43% |
| Nursing and Health Professions | 38 | 10% |
| Agricultural and Biological Sciences | 17 | 4% |
| Social Sciences | 15 | 4% |
| Psychology | 11 | 3% |
| Other | 50 | 13% |
| Unknown | 97 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2021.
All research outputs
#1,544,333
of 25,374,647 outputs
Outputs from PLOS Medicine
#2,082
of 5,161 outputs
Outputs of similar age
#8,549
of 176,330 outputs
Outputs of similar age from PLOS Medicine
#33
of 47 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,161 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 77.7. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,330 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.